Cyclobenzaprine Hydrochloride
Product Images NDC 61919-537

2 FDA label images from Direct_rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 61919-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

05 (305 30)

05 (305 30)
The packaging label for CYCLOBENZAPRINE HYDROCHLORIDE 5 mg, tablets, contains 30 tablets in a unit dose strip. Labeled as a generic for FLEXERIL, this product is registered to Direct Rx and manufactured by Cipla USA Inc., Miami, FL. The label includes warnings about drowsiness and instructions to keep the medication out of reach of children.*
FDA Label Image

537 90

537 90
Label for Cyclobenzaprine Hydrochloride 10 mg, 90 tablets, generic for Flexeril. The label indicates the active ingredient strength and quantity, with manufacturer information from Direct Rx. It includes standard cautionary text about federal law restrictions and warnings about drowsiness and alcohol use, as well as batch and expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.